Stocks and Investing
by (remove) : Edwin Zhang
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Edwin Zhang
RSSJSONXMLCSV

Edwin Zhang Reiterated (CALT) at Strong Buy and Held Target at $50 on, Oct 16th, 2023


Published on 2024-10-28 06:54:31 - WOPRAI, Edwin Zhang
  Print publication without navigation


Edwin Zhang of HC Wainwright & Co., Reiterated "Calliditas Therapeutics AB (publ)" (CALT) at Strong Buy and Held Target at $50 on, Oct 16th, 2023.

Edwin has made no other calls on CALT in the last 4 months.



There is 1 other peer that has a rating on CALT. Out of the 1 peers that are also analyzing CALT, all agrees with Edwin's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vamil Divan of "Guggenheim" Maintained at Hold with Decreased Target to $18 on, Friday, August 18th, 2023
Contributing Sources